Nonheparin anticoagulants for heparin-induced thrombocytopenia

N Engl J Med. 2013 Feb 21;368(8):737-44. doi: 10.1056/NEJMct1206642.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies / blood
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Antithrombins / therapeutic use*
  • Arthroplasty, Replacement, Knee
  • Chondroitin Sulfates / therapeutic use
  • Dermatan Sulfate / therapeutic use
  • Fondaparinux
  • Heparin / immunology
  • Heparin / metabolism
  • Heparin, Low-Molecular-Weight / adverse effects*
  • Heparitin Sulfate / therapeutic use
  • Humans
  • Immunoglobulin G / physiology
  • Male
  • Middle Aged
  • Platelet Activation / immunology
  • Platelet Count
  • Platelet Factor 4 / immunology
  • Platelet Factor 4 / metabolism
  • Polysaccharides / therapeutic use
  • Practice Guidelines as Topic
  • Thrombocytopenia / chemically induced
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / drug therapy*
  • Venous Thrombosis
  • Vitamin K / antagonists & inhibitors

Substances

  • Antibodies
  • Anticoagulants
  • Antithrombins
  • Heparin, Low-Molecular-Weight
  • Immunoglobulin G
  • Polysaccharides
  • Vitamin K
  • Dermatan Sulfate
  • Platelet Factor 4
  • Heparin
  • Chondroitin Sulfates
  • Heparitin Sulfate
  • danaparoid
  • Fondaparinux